Added to YB: 2022-06-10
Pitch date: 2022-06-10
CBAY [bullish]
CymaBay Therapeutics, Inc.
+1403.7%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases.
Market Cap
$3.7B
Pitch Price
$2.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
-34.17
P/E
-32.74
EV/Sales
110.30
Sector
Pharmaceuticals
Category
N/A
Show full summary:
CYMABAY THERAPEUTICS INC CBAY
A summary for this pitch has not been created yet.
Read full article (0 min)